Biomarkers of Androgen Response and Resistance In Evolution During a Rising PSA

NCT02429193 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Castration-resistant Prostate Cancer

Interventions

DRUG: Abiraterone + prednisone
DRUG: Enzalutamide

Sponsor

University Health Network, Toronto